John Patience, Director at Accelerate Diagnostics, Inc (AXDX), bought 200,000 shares at $1.57 ($314K) on 2024-12-03, disclosed to the SEC on 2024-12-03.
Open-market purchase of $314k AXDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BDSX | BUY | 2022-04-11 | $1000K | — | Filing → |
| BDSX | BUY | 2022-01-04 | $1.4M | — | Filing → |
| BDSX | BUY | 2021-11-24 | $62K | — | Filing → |